Citrus Bergamot Supplement Endothelial Function Randomized Trial Evidence Table

Structured evidence table for Citrus Bergamot Supplement Endothelial Function Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Citrus Bergamot Supplement Endothelial Function Randomized TrialMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), has emerged as the most prevalent chronic liver disease worldwide, with an overall global prevalence of 30% [...].4Rodriguez-Ramiro I (2026)Advances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside.
topicCitrus Bergamot Supplement Endothelial Function Randomized Trial
claimMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), has emerged as the most prevalent chronic liver disease worldwide, with an overall global prevalence of 30% [...].
evidence level4
citationRodriguez-Ramiro I (2026)
sourceAdvances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside.

Source documents

  1. Advances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside.